| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3K | — | +0.0% |
| R&D Expense | $455K | +7.3% | +32.5% |
| SG&A Expense | $349K | +436.0% | +390.5% |
| Operating Income | -$1.2M | -45.6% | -138.8% |
| Pre-tax Income | -$1.5M | -25.2% | -197.9% |
| Net Income | -$1.5M | -25.2% | -201.8% |
| EPS (Basic) | -$0.08 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $484K | +200.0% | +308.8% |
| Total Assets | $75.9M | -0.3% | +265.1% |
| Current Liabilities | $1.0M | -37.8% | +558.7% |
| Total Liabilities | $11.2M | -5.5% | +7236.7% |
| Stockholders' Equity | $64.7M | +0.6% | +228.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.2M | -414.1% | — |
| Capital Expenditures | $11K | — | — |
| Investing Cash Flow | -$11K | — | — |
| Financing Cash Flow | $2.4M | +490.1% | — |
| Free Cash Flow | -$2.2M | — | — |
| +20.0% |
| EPS (Diluted) | -$0.08 | -14.3% | +20.0% |